The state awarded five life sciences companies $200,000 apiece through the BioMaryland Center, a division within the state Department of Business and Economic Development.
The companies, which received up to $200,000 each, will use the funding to advance the early detection of Alzheimer’s disease, create a less-invasive treatment for tachycardia patients, enhance animal analgesics, control traumatic bleeds and develop high-quality gluten and allergen-free kosher food products.
Companies receiving awards this round include:
- Baltimore-based Animalgesic Labs, which is manufacturing its first batch of FDA authorized pain medication
- Baltimore-based Cardiosolv, which is undertaking a study to create a less-invasive treatment for tachycardia patients.
- Rockville-based Adlyfe, which is commercializing technologies for the early detection of Alzheimer’s disease
- Columbia-based CrispTek, which is developing and marketing three new certified gluten and allergen-free baking mixes
- College Park-based Remedium Technologies, which is working on advancing its Hemogrip TM, a proprietary lifesaving technology to stop traumatic bleeding.
Knowledge is power!
Subscribe for free today and stay up to date with news and tips you need to grow your career and connect with our vibrant tech community.